The announcement on 22 May confirmed Ido's commencement as CEO. It was announced as non price sensitive and rightly so as we were informed early this year about it. therefore not much price action.
but imminent news on Neuvis, clinical trials and export, things could get heated really really REALLY quickly
don't miss the boat
DYOR
The announcement on 22 May confirmed Ido's commencement as...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AC8 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AC8 (ASX) Chart |
Day chart unavailable